The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC).
 
Rodrigo Dienstmann
No Relationships to Disclose
 
Sabine Tejpar
Honoraria - Merck Serono; Regeneron
Consulting or Advisory Role - Bayer; Merck Serono; Regeneron
Speakers' Bureau - Merck Serono; Roche; Sanofi
Research Funding - Merck Serono (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi
 
Frank A. Sinicrope
Stock and Other Ownership Interests - Gilead Sciences; illumina
Consulting or Advisory Role - Ventana Medical Systems
Travel, Accommodations, Expenses - ventana medical systems
 
Amanda I. Phipps
No Relationships to Disclose
 
Brian Bot
No Relationships to Disclose
 
Stephen Henry Friend
No Relationships to Disclose
 
Mauro Delorenzi
No Relationships to Disclose
 
Polly A. Newcomb
No Relationships to Disclose
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
John M Jessup
No Relationships to Disclose
 
Justin Guinney
No Relationships to Disclose